nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2A6—Pilocarpine—glaucoma	0.232	0.659	CbGbCtD
Memantine—CYP2C19—Methazolamide—glaucoma	0.065	0.184	CbGbCtD
Memantine—CYP2C19—Timolol—glaucoma	0.0552	0.157	CbGbCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00052	0.00645	CbGpPWpGaD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—glaucoma	0.000513	0.00636	CbGpPWpGaD
Memantine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000502	0.00623	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—APOE—glaucoma	0.000501	0.00622	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—SLC6A13—glaucoma	0.000477	0.00592	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—FAS—glaucoma	0.000476	0.00591	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—BAD—glaucoma	0.000467	0.00579	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—SLC6A13—glaucoma	0.000465	0.00577	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—FAS—glaucoma	0.000464	0.00576	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—NGFR—glaucoma	0.000464	0.00576	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000462	0.00574	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—NTRK2—glaucoma	0.000461	0.00572	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000456	0.00566	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00045	0.00559	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—NTRK2—glaucoma	0.000449	0.00558	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000444	0.00552	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—APOE—glaucoma	0.000437	0.00542	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000432	0.00537	CbGpPWpGaD
Memantine—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000431	0.00535	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—APOE—glaucoma	0.000426	0.00529	CbGpPWpGaD
Memantine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000423	0.00525	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—BAD—glaucoma	0.000407	0.00505	CbGpPWpGaD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000404	0.00501	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—BDNF—glaucoma	0.000403	0.00501	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—SLC6A1—glaucoma	0.0004	0.00497	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—BAD—glaucoma	0.000397	0.00493	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—NCK2—glaucoma	0.000396	0.00492	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—NGFR—glaucoma	0.000396	0.00491	CbGpPWpGaD
Memantine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000395	0.0049	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000393	0.00488	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—OPN4—glaucoma	0.00039	0.00484	CbGpPWpGaD
Memantine—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00039	0.00484	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000388	0.00481	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL1A—glaucoma	0.000387	0.00481	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—NCK2—glaucoma	0.000386	0.00479	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—NGFR—glaucoma	0.000386	0.00479	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—SLC6A13—glaucoma	0.000382	0.00475	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—NTRK1—glaucoma	0.000376	0.00467	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000372	0.00462	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—NTRK1—glaucoma	0.000366	0.00455	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000349	0.00434	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—SLC6A1—glaucoma	0.000349	0.00434	CbGpPWpGaD
Memantine—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000348	0.00433	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—NGF—glaucoma	0.000344	0.00427	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—BDNF—glaucoma	0.000344	0.00427	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000343	0.00425	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—SLC6A1—glaucoma	0.00034	0.00423	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—BDNF—glaucoma	0.000335	0.00416	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000324	0.00402	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000323	0.00401	CbGpPWpGaD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00032	0.00398	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000319	0.00397	CbGpPWpGaD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000319	0.00396	CbGpPWpGaD
Memantine—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000315	0.0039	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—TXN—glaucoma	0.000314	0.0039	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00031	0.00385	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000308	0.00383	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—NGF—glaucoma	0.000305	0.00379	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—MMP2—glaucoma	0.000304	0.00377	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—NGF—glaucoma	0.000298	0.0037	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—MMP2—glaucoma	0.000296	0.00368	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000296	0.00367	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000288	0.00357	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—NGF—glaucoma	0.000286	0.00356	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000285	0.00354	CbGpPWpGaD
Memantine—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000283	0.00352	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NCK2—glaucoma	0.000283	0.00351	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—SLC6A1—glaucoma	0.00028	0.00347	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000279	0.00346	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NCK2—glaucoma	0.000275	0.00342	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000274	0.0034	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000262	0.00326	CbGpPWpGaD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000258	0.00321	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—BAD—glaucoma	0.000252	0.00313	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—SLC6A13—glaucoma	0.000248	0.00308	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000246	0.00306	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—BAD—glaucoma	0.000246	0.00305	CbGpPWpGaD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000241	0.00299	CbGpPWpGaD
Memantine—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000238	0.00295	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000237	0.00294	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TNF—glaucoma	0.000232	0.00288	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—MMP9—glaucoma	0.000229	0.00284	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—TGFB2—glaucoma	0.000228	0.00283	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000226	0.0028	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—MMP9—glaucoma	0.000223	0.00277	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—PTGS2—glaucoma	0.000217	0.0027	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—GSTT1—glaucoma	0.000213	0.00265	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—OPN4—glaucoma	0.000208	0.00259	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CDKN1B—glaucoma	0.000206	0.00255	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—VEGFA—glaucoma	0.000205	0.00255	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—glaucoma	0.000204	0.00254	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—TNF—glaucoma	0.000202	0.00251	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—VEGFA—glaucoma	0.0002	0.00248	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.0002	0.00248	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TNF—glaucoma	0.000197	0.00245	CbGpPWpGaD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000195	0.00242	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000192	0.00238	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—MMP9—glaucoma	0.00019	0.00236	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—PTGFR—glaucoma	0.000188	0.00233	CbGpPWpGaD
Memantine—Decreased appetite—Pilocarpine—glaucoma	0.000187	0.00033	CcSEcCtD
Memantine—Feeling abnormal—Travoprost—glaucoma	0.000187	0.00033	CcSEcCtD
Memantine—Conjunctivitis—Timolol—glaucoma	0.000187	0.000329	CcSEcCtD
Memantine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000186	0.000329	CcSEcCtD
Memantine—Alopecia—Betaxolol—glaucoma	0.000186	0.000329	CcSEcCtD
Memantine—Palpitations—Clonidine—glaucoma	0.000186	0.000329	CcSEcCtD
Memantine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000186	0.000328	CcSEcCtD
Memantine—Gastrointestinal pain—Travoprost—glaucoma	0.000186	0.000328	CcSEcCtD
Memantine—Loss of consciousness—Clonidine—glaucoma	0.000185	0.000327	CcSEcCtD
Memantine—Feeling abnormal—Brinzolamide—glaucoma	0.000185	0.000326	CcSEcCtD
Memantine—Mental disorder—Betaxolol—glaucoma	0.000185	0.000326	CcSEcCtD
Memantine—Constipation—Pilocarpine—glaucoma	0.000184	0.000325	CcSEcCtD
Memantine—Pain—Pilocarpine—glaucoma	0.000184	0.000325	CcSEcCtD
Memantine—Cough—Clonidine—glaucoma	0.000184	0.000325	CcSEcCtD
Memantine—Dizziness—Apraclonidine—glaucoma	0.000184	0.000324	CcSEcCtD
Memantine—Malnutrition—Betaxolol—glaucoma	0.000184	0.000324	CcSEcCtD
Memantine—GRIN1—Developmental Biology—PAX6—glaucoma	0.000183	0.00227	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—SLC6A1—glaucoma	0.000182	0.00225	CbGpPWpGaD
Memantine—Urticaria—Dorzolamide—glaucoma	0.000181	0.00032	CcSEcCtD
Memantine—Epistaxis—Timolol—glaucoma	0.000181	0.000319	CcSEcCtD
Memantine—Body temperature increased—Dorzolamide—glaucoma	0.00018	0.000318	CcSEcCtD
Memantine—Abdominal pain—Dorzolamide—glaucoma	0.00018	0.000318	CcSEcCtD
Memantine—Tension—Betaxolol—glaucoma	0.00018	0.000318	CcSEcCtD
Memantine—Sinusitis—Timolol—glaucoma	0.00018	0.000318	CcSEcCtD
Memantine—Dysgeusia—Betaxolol—glaucoma	0.00018	0.000317	CcSEcCtD
Memantine—Arthralgia—Clonidine—glaucoma	0.000179	0.000317	CcSEcCtD
Memantine—Chest pain—Clonidine—glaucoma	0.000179	0.000317	CcSEcCtD
Memantine—Abdominal pain—Travoprost—glaucoma	0.000179	0.000317	CcSEcCtD
Memantine—Agranulocytosis—Timolol—glaucoma	0.000179	0.000316	CcSEcCtD
Memantine—Anxiety—Clonidine—glaucoma	0.000179	0.000316	CcSEcCtD
Memantine—Asthenia—Acetazolamide—glaucoma	0.000178	0.000315	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—PAX6—glaucoma	0.000178	0.00221	CbGpPWpGaD
Memantine—Dizziness—Bimatoprost—glaucoma	0.000178	0.000315	CcSEcCtD
Memantine—Nervousness—Betaxolol—glaucoma	0.000178	0.000315	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—TP53—glaucoma	0.000178	0.00221	CbGpPWpGaD
Memantine—Urticaria—Brinzolamide—glaucoma	0.000178	0.000314	CcSEcCtD
Memantine—Feeling abnormal—Pilocarpine—glaucoma	0.000178	0.000313	CcSEcCtD
Memantine—Discomfort—Clonidine—glaucoma	0.000177	0.000313	CcSEcCtD
Memantine—Vomiting—Apraclonidine—glaucoma	0.000177	0.000312	CcSEcCtD
Memantine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000176	0.000311	CcSEcCtD
Memantine—Hypersensitivity—Brimonidine—glaucoma	0.000176	0.00031	CcSEcCtD
Memantine—Dry mouth—Clonidine—glaucoma	0.000176	0.00031	CcSEcCtD
Memantine—Bradycardia—Timolol—glaucoma	0.000175	0.000309	CcSEcCtD
Memantine—Dermatitis—Apraclonidine—glaucoma	0.000175	0.000309	CcSEcCtD
Memantine—Headache—Apraclonidine—glaucoma	0.000174	0.000307	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—TP53—glaucoma	0.000174	0.00216	CbGpPWpGaD
Memantine—Confusional state—Clonidine—glaucoma	0.000173	0.000306	CcSEcCtD
Memantine—Vision blurred—Betaxolol—glaucoma	0.000173	0.000305	CcSEcCtD
Memantine—Rhinitis—Timolol—glaucoma	0.000173	0.000305	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—GSTT1—glaucoma	0.000172	0.00214	CbGpPWpGaD
Memantine—Oedema—Clonidine—glaucoma	0.000172	0.000304	CcSEcCtD
Memantine—Tremor—Betaxolol—glaucoma	0.000172	0.000303	CcSEcCtD
Memantine—Hallucination—Timolol—glaucoma	0.000171	0.000302	CcSEcCtD
Memantine—Asthenia—Brimonidine—glaucoma	0.000171	0.000302	CcSEcCtD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—glaucoma	0.000171	0.00212	CbGpPWpGaD
Memantine—Infection—Clonidine—glaucoma	0.000171	0.000302	CcSEcCtD
Memantine—Abdominal pain—Pilocarpine—glaucoma	0.00017	0.000301	CcSEcCtD
Memantine—Body temperature increased—Pilocarpine—glaucoma	0.00017	0.000301	CcSEcCtD
Memantine—Ill-defined disorder—Betaxolol—glaucoma	0.00017	0.0003	CcSEcCtD
Memantine—Diarrhoea—Acetazolamide—glaucoma	0.00017	0.0003	CcSEcCtD
Memantine—CYP2A6—Biological oxidations—CYP1B1—glaucoma	0.00017	0.00211	CbGpPWpGaD
Memantine—Rash—Bimatoprost—glaucoma	0.00017	0.0003	CcSEcCtD
Memantine—Dermatitis—Bimatoprost—glaucoma	0.00017	0.0003	CcSEcCtD
Memantine—Oedema peripheral—Timolol—glaucoma	0.00017	0.000299	CcSEcCtD
Memantine—Anaemia—Betaxolol—glaucoma	0.00017	0.000299	CcSEcCtD
Memantine—Shock—Clonidine—glaucoma	0.000169	0.000299	CcSEcCtD
Memantine—Connective tissue disorder—Timolol—glaucoma	0.000169	0.000299	CcSEcCtD
Memantine—Pruritus—Brimonidine—glaucoma	0.000169	0.000298	CcSEcCtD
Memantine—Headache—Bimatoprost—glaucoma	0.000169	0.000298	CcSEcCtD
Memantine—Nervous system disorder—Clonidine—glaucoma	0.000169	0.000298	CcSEcCtD
Memantine—Thrombocytopenia—Clonidine—glaucoma	0.000168	0.000297	CcSEcCtD
Memantine—Hypersensitivity—Dorzolamide—glaucoma	0.000168	0.000296	CcSEcCtD
Memantine—Tachycardia—Clonidine—glaucoma	0.000168	0.000296	CcSEcCtD
Memantine—Hypersensitivity—Travoprost—glaucoma	0.000167	0.000295	CcSEcCtD
Memantine—Skin disorder—Clonidine—glaucoma	0.000167	0.000295	CcSEcCtD
Memantine—Hyperhidrosis—Clonidine—glaucoma	0.000166	0.000293	CcSEcCtD
Memantine—Visual impairment—Timolol—glaucoma	0.000166	0.000293	CcSEcCtD
Memantine—Malaise—Betaxolol—glaucoma	0.000166	0.000292	CcSEcCtD
Memantine—Nausea—Apraclonidine—glaucoma	0.000165	0.000291	CcSEcCtD
Memantine—Hypersensitivity—Brinzolamide—glaucoma	0.000165	0.000291	CcSEcCtD
Memantine—Vertigo—Betaxolol—glaucoma	0.000165	0.000291	CcSEcCtD
Memantine—Syncope—Betaxolol—glaucoma	0.000165	0.00029	CcSEcCtD
Memantine—Dizziness—Acetazolamide—glaucoma	0.000165	0.00029	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000164	0.00204	CbGpPWpGaD
Memantine—Anorexia—Clonidine—glaucoma	0.000164	0.000289	CcSEcCtD
Memantine—Asthenia—Dorzolamide—glaucoma	0.000164	0.000289	CcSEcCtD
Memantine—SLC22A2—Metabolism—CA5A—glaucoma	0.000163	0.00202	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NARFL—glaucoma	0.000163	0.00202	CbGpPWpGaD
Memantine—Asthenia—Travoprost—glaucoma	0.000163	0.000287	CcSEcCtD
Memantine—Palpitations—Betaxolol—glaucoma	0.000162	0.000286	CcSEcCtD
Memantine—Pruritus—Dorzolamide—glaucoma	0.000161	0.000285	CcSEcCtD
Memantine—Loss of consciousness—Betaxolol—glaucoma	0.000161	0.000285	CcSEcCtD
Memantine—Eye disorder—Timolol—glaucoma	0.000161	0.000284	CcSEcCtD
Memantine—Asthenia—Brinzolamide—glaucoma	0.000161	0.000284	CcSEcCtD
Memantine—Hypotension—Clonidine—glaucoma	0.000161	0.000284	CcSEcCtD
Memantine—Pruritus—Travoprost—glaucoma	0.000161	0.000283	CcSEcCtD
Memantine—Tinnitus—Timolol—glaucoma	0.000161	0.000283	CcSEcCtD
Memantine—Cough—Betaxolol—glaucoma	0.00016	0.000283	CcSEcCtD
Memantine—Nausea—Bimatoprost—glaucoma	0.00016	0.000283	CcSEcCtD
Memantine—Cardiac disorder—Timolol—glaucoma	0.00016	0.000282	CcSEcCtD
Memantine—Hypersensitivity—Pilocarpine—glaucoma	0.000159	0.00028	CcSEcCtD
Memantine—Pruritus—Brinzolamide—glaucoma	0.000159	0.00028	CcSEcCtD
Memantine—Vomiting—Acetazolamide—glaucoma	0.000158	0.000279	CcSEcCtD
Memantine—Dizziness—Brimonidine—glaucoma	0.000158	0.000279	CcSEcCtD
Memantine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000157	0.000277	CcSEcCtD
Memantine—Angiopathy—Timolol—glaucoma	0.000156	0.000276	CcSEcCtD
Memantine—Arthralgia—Betaxolol—glaucoma	0.000156	0.000276	CcSEcCtD
Memantine—Chest pain—Betaxolol—glaucoma	0.000156	0.000276	CcSEcCtD
Memantine—Myalgia—Betaxolol—glaucoma	0.000156	0.000276	CcSEcCtD
Memantine—Diarrhoea—Dorzolamide—glaucoma	0.000156	0.000275	CcSEcCtD
Memantine—Headache—Acetazolamide—glaucoma	0.000156	0.000275	CcSEcCtD
Memantine—Anxiety—Betaxolol—glaucoma	0.000156	0.000275	CcSEcCtD
Memantine—Insomnia—Clonidine—glaucoma	0.000156	0.000275	CcSEcCtD
Memantine—Immune system disorder—Timolol—glaucoma	0.000156	0.000275	CcSEcCtD
Memantine—Diarrhoea—Travoprost—glaucoma	0.000155	0.000274	CcSEcCtD
Memantine—Mediastinal disorder—Timolol—glaucoma	0.000155	0.000274	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—GSTM1—glaucoma	0.000155	0.00192	CbGpPWpGaD
Memantine—Asthenia—Pilocarpine—glaucoma	0.000155	0.000273	CcSEcCtD
Memantine—Paraesthesia—Clonidine—glaucoma	0.000155	0.000273	CcSEcCtD
Memantine—Discomfort—Betaxolol—glaucoma	0.000154	0.000272	CcSEcCtD
Memantine—Arrhythmia—Timolol—glaucoma	0.000154	0.000272	CcSEcCtD
Memantine—Dyspnoea—Clonidine—glaucoma	0.000153	0.000271	CcSEcCtD
Memantine—Diarrhoea—Brinzolamide—glaucoma	0.000153	0.000271	CcSEcCtD
Memantine—Somnolence—Clonidine—glaucoma	0.000153	0.00027	CcSEcCtD
Memantine—Dry mouth—Betaxolol—glaucoma	0.000153	0.00027	CcSEcCtD
Memantine—Pruritus—Pilocarpine—glaucoma	0.000152	0.000269	CcSEcCtD
Memantine—Alopecia—Timolol—glaucoma	0.000152	0.000269	CcSEcCtD
Memantine—Confusional state—Betaxolol—glaucoma	0.000151	0.000267	CcSEcCtD
Memantine—Mental disorder—Timolol—glaucoma	0.000151	0.000266	CcSEcCtD
Memantine—Dizziness—Dorzolamide—glaucoma	0.000151	0.000266	CcSEcCtD
Memantine—Rash—Brimonidine—glaucoma	0.000151	0.000266	CcSEcCtD
Memantine—Dermatitis—Brimonidine—glaucoma	0.00015	0.000265	CcSEcCtD
Memantine—Dizziness—Travoprost—glaucoma	0.00015	0.000265	CcSEcCtD
Memantine—Malnutrition—Timolol—glaucoma	0.00015	0.000265	CcSEcCtD
Memantine—Oedema—Betaxolol—glaucoma	0.00015	0.000264	CcSEcCtD
Memantine—CYP2A6—Metabolism—CA5A—glaucoma	0.00015	0.00186	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NARFL—glaucoma	0.00015	0.00186	CbGpPWpGaD
Memantine—Headache—Brimonidine—glaucoma	0.00015	0.000264	CcSEcCtD
Memantine—Decreased appetite—Clonidine—glaucoma	0.00015	0.000264	CcSEcCtD
Memantine—Infection—Betaxolol—glaucoma	0.000149	0.000263	CcSEcCtD
Memantine—Gastrointestinal disorder—Clonidine—glaucoma	0.000149	0.000262	CcSEcCtD
Memantine—Fatigue—Clonidine—glaucoma	0.000148	0.000262	CcSEcCtD
Memantine—Dizziness—Brinzolamide—glaucoma	0.000148	0.000262	CcSEcCtD
Memantine—Nausea—Acetazolamide—glaucoma	0.000148	0.000261	CcSEcCtD
Memantine—Diarrhoea—Pilocarpine—glaucoma	0.000147	0.00026	CcSEcCtD
Memantine—Shock—Betaxolol—glaucoma	0.000147	0.00026	CcSEcCtD
Memantine—Tension—Timolol—glaucoma	0.000147	0.00026	CcSEcCtD
Memantine—Constipation—Clonidine—glaucoma	0.000147	0.00026	CcSEcCtD
Memantine—Pain—Clonidine—glaucoma	0.000147	0.00026	CcSEcCtD
Memantine—Nervous system disorder—Betaxolol—glaucoma	0.000147	0.000259	CcSEcCtD
Memantine—Dysgeusia—Timolol—glaucoma	0.000147	0.000259	CcSEcCtD
Memantine—Thrombocytopenia—Betaxolol—glaucoma	0.000147	0.000259	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—TNF—glaucoma	0.000147	0.00182	CbGpPWpGaD
Memantine—Tachycardia—Betaxolol—glaucoma	0.000146	0.000258	CcSEcCtD
Memantine—Nervousness—Timolol—glaucoma	0.000146	0.000257	CcSEcCtD
Memantine—Skin disorder—Betaxolol—glaucoma	0.000146	0.000257	CcSEcCtD
Memantine—Vomiting—Dorzolamide—glaucoma	0.000145	0.000256	CcSEcCtD
Memantine—Hyperhidrosis—Betaxolol—glaucoma	0.000145	0.000256	CcSEcCtD
Memantine—Rash—Dorzolamide—glaucoma	0.000144	0.000254	CcSEcCtD
Memantine—Dermatitis—Dorzolamide—glaucoma	0.000144	0.000253	CcSEcCtD
Memantine—Rash—Travoprost—glaucoma	0.000143	0.000253	CcSEcCtD
Memantine—Dermatitis—Travoprost—glaucoma	0.000143	0.000252	CcSEcCtD
Memantine—Headache—Dorzolamide—glaucoma	0.000143	0.000252	CcSEcCtD
Memantine—Anorexia—Betaxolol—glaucoma	0.000143	0.000252	CcSEcCtD
Memantine—Vomiting—Brinzolamide—glaucoma	0.000143	0.000251	CcSEcCtD
Memantine—Dizziness—Pilocarpine—glaucoma	0.000142	0.000251	CcSEcCtD
Memantine—Headache—Travoprost—glaucoma	0.000142	0.000251	CcSEcCtD
Memantine—Nausea—Brimonidine—glaucoma	0.000142	0.00025	CcSEcCtD
Memantine—Feeling abnormal—Clonidine—glaucoma	0.000142	0.00025	CcSEcCtD
Memantine—Rash—Brinzolamide—glaucoma	0.000141	0.000249	CcSEcCtD
Memantine—Vision blurred—Timolol—glaucoma	0.000141	0.000249	CcSEcCtD
Memantine—Dermatitis—Brinzolamide—glaucoma	0.000141	0.000249	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—TNF—glaucoma	0.000141	0.00175	CbGpPWpGaD
Memantine—Gastrointestinal pain—Clonidine—glaucoma	0.000141	0.000248	CcSEcCtD
Memantine—Headache—Brinzolamide—glaucoma	0.00014	0.000248	CcSEcCtD
Memantine—Hypotension—Betaxolol—glaucoma	0.00014	0.000247	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—NGFR—glaucoma	0.000139	0.00173	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—CYP1B1—glaucoma	0.000137	0.0017	CbGpPWpGaD
Memantine—Vomiting—Pilocarpine—glaucoma	0.000137	0.000242	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000137	0.0017	CbGpPWpGaD
Memantine—Urticaria—Clonidine—glaucoma	0.000137	0.000241	CcSEcCtD
Memantine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000136	0.000241	CcSEcCtD
Memantine—Abdominal pain—Clonidine—glaucoma	0.000136	0.00024	CcSEcCtD
Memantine—Body temperature increased—Clonidine—glaucoma	0.000136	0.00024	CcSEcCtD
Memantine—CYP2A6—Biological oxidations—GSTM1—glaucoma	0.000136	0.00169	CbGpPWpGaD
Memantine—Rash—Pilocarpine—glaucoma	0.000136	0.00024	CcSEcCtD
Memantine—Dermatitis—Pilocarpine—glaucoma	0.000136	0.000239	CcSEcCtD
Memantine—Insomnia—Betaxolol—glaucoma	0.000135	0.000239	CcSEcCtD
Memantine—Nausea—Dorzolamide—glaucoma	0.000135	0.000239	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	0.000135	0.00168	CbGpPWpGaD
Memantine—Headache—Pilocarpine—glaucoma	0.000135	0.000238	CcSEcCtD
Memantine—Nausea—Travoprost—glaucoma	0.000135	0.000238	CcSEcCtD
Memantine—Vertigo—Timolol—glaucoma	0.000135	0.000238	CcSEcCtD
Memantine—Paraesthesia—Betaxolol—glaucoma	0.000135	0.000237	CcSEcCtD
Memantine—Syncope—Timolol—glaucoma	0.000134	0.000237	CcSEcCtD
Memantine—Dyspnoea—Betaxolol—glaucoma	0.000134	0.000236	CcSEcCtD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000133	0.00166	CbGpPWpGaD
Memantine—Nausea—Brinzolamide—glaucoma	0.000133	0.000235	CcSEcCtD
Memantine—Palpitations—Timolol—glaucoma	0.000133	0.000234	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—NTRK1—glaucoma	0.000132	0.00164	CbGpPWpGaD
Memantine—Dyspepsia—Betaxolol—glaucoma	0.000132	0.000233	CcSEcCtD
Memantine—Loss of consciousness—Timolol—glaucoma	0.000132	0.000233	CcSEcCtD
Memantine—Cough—Timolol—glaucoma	0.000131	0.000231	CcSEcCtD
Memantine—Decreased appetite—Betaxolol—glaucoma	0.00013	0.00023	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—GSTT1—glaucoma	0.00013	0.00162	CbGpPWpGaD
Memantine—Hypertension—Timolol—glaucoma	0.000129	0.000228	CcSEcCtD
Memantine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000129	0.000228	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—TP53—glaucoma	0.000129	0.0016	CbGpPWpGaD
Memantine—Fatigue—Betaxolol—glaucoma	0.000129	0.000228	CcSEcCtD
Memantine—Constipation—Betaxolol—glaucoma	0.000128	0.000226	CcSEcCtD
Memantine—Pain—Betaxolol—glaucoma	0.000128	0.000226	CcSEcCtD
Memantine—Nausea—Pilocarpine—glaucoma	0.000128	0.000226	CcSEcCtD
Memantine—Myalgia—Timolol—glaucoma	0.000128	0.000225	CcSEcCtD
Memantine—Arthralgia—Timolol—glaucoma	0.000128	0.000225	CcSEcCtD
Memantine—Chest pain—Timolol—glaucoma	0.000128	0.000225	CcSEcCtD
Memantine—Anxiety—Timolol—glaucoma	0.000127	0.000224	CcSEcCtD
Memantine—Hypersensitivity—Clonidine—glaucoma	0.000127	0.000224	CcSEcCtD
Memantine—Discomfort—Timolol—glaucoma	0.000126	0.000223	CcSEcCtD
Memantine—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	0.000126	0.00156	CbGpPWpGaD
Memantine—Dry mouth—Timolol—glaucoma	0.000125	0.00022	CcSEcCtD
Memantine—Asthenia—Clonidine—glaucoma	0.000123	0.000218	CcSEcCtD
Memantine—Feeling abnormal—Betaxolol—glaucoma	0.000123	0.000218	CcSEcCtD
Memantine—Confusional state—Timolol—glaucoma	0.000123	0.000218	CcSEcCtD
Memantine—Oedema—Timolol—glaucoma	0.000122	0.000216	CcSEcCtD
Memantine—Pruritus—Clonidine—glaucoma	0.000122	0.000215	CcSEcCtD
Memantine—Infection—Timolol—glaucoma	0.000122	0.000215	CcSEcCtD
Memantine—CYP2B6—Metabolism—CA5A—glaucoma	0.000121	0.0015	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NARFL—glaucoma	0.000121	0.0015	CbGpPWpGaD
Memantine—Shock—Timolol—glaucoma	0.00012	0.000212	CcSEcCtD
Memantine—Nervous system disorder—Timolol—glaucoma	0.00012	0.000212	CcSEcCtD
Memantine—Urticaria—Betaxolol—glaucoma	0.000119	0.00021	CcSEcCtD
Memantine—Skin disorder—Timolol—glaucoma	0.000119	0.00021	CcSEcCtD
Memantine—Body temperature increased—Betaxolol—glaucoma	0.000118	0.000209	CcSEcCtD
Memantine—Hyperhidrosis—Timolol—glaucoma	0.000118	0.000209	CcSEcCtD
Memantine—DRD2—GPCR downstream signaling—OPN4—glaucoma	0.000118	0.00146	CbGpPWpGaD
Memantine—Diarrhoea—Clonidine—glaucoma	0.000118	0.000208	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—TNF—glaucoma	0.000117	0.00146	CbGpPWpGaD
Memantine—Anorexia—Timolol—glaucoma	0.000117	0.000206	CcSEcCtD
Memantine—Hypotension—Timolol—glaucoma	0.000114	0.000202	CcSEcCtD
Memantine—Dizziness—Clonidine—glaucoma	0.000114	0.000201	CcSEcCtD
Memantine—GRIN1—Axon guidance—MMP2—glaucoma	0.000113	0.0014	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Timolol—glaucoma	0.000111	0.000197	CcSEcCtD
Memantine—Insomnia—Timolol—glaucoma	0.000111	0.000195	CcSEcCtD
Memantine—Hypersensitivity—Betaxolol—glaucoma	0.00011	0.000195	CcSEcCtD
Memantine—GRIN2B—Axon guidance—MMP2—glaucoma	0.00011	0.00137	CbGpPWpGaD
Memantine—Paraesthesia—Timolol—glaucoma	0.00011	0.000194	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—GSTM1—glaucoma	0.00011	0.00136	CbGpPWpGaD
Memantine—Vomiting—Clonidine—glaucoma	0.000109	0.000193	CcSEcCtD
Memantine—Dyspnoea—Timolol—glaucoma	0.000109	0.000193	CcSEcCtD
Memantine—Somnolence—Timolol—glaucoma	0.000109	0.000192	CcSEcCtD
Memantine—Rash—Clonidine—glaucoma	0.000108	0.000191	CcSEcCtD
Memantine—Dermatitis—Clonidine—glaucoma	0.000108	0.000191	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	0.000108	0.00134	CbGpPWpGaD
Memantine—Headache—Clonidine—glaucoma	0.000108	0.00019	CcSEcCtD
Memantine—Dyspepsia—Timolol—glaucoma	0.000108	0.00019	CcSEcCtD
Memantine—Asthenia—Betaxolol—glaucoma	0.000107	0.00019	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—OPN4—glaucoma	0.000107	0.00133	CbGpPWpGaD
Memantine—Decreased appetite—Timolol—glaucoma	0.000106	0.000188	CcSEcCtD
Memantine—DRD2—GPCR downstream signaling—PTGFR—glaucoma	0.000106	0.00132	CbGpPWpGaD
Memantine—Pruritus—Betaxolol—glaucoma	0.000106	0.000187	CcSEcCtD
Memantine—Gastrointestinal disorder—Timolol—glaucoma	0.000106	0.000186	CcSEcCtD
Memantine—Fatigue—Timolol—glaucoma	0.000106	0.000186	CcSEcCtD
Memantine—Pain—Timolol—glaucoma	0.000105	0.000185	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—CYP1B1—glaucoma	0.000104	0.00129	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—FAS—glaucoma	0.000103	0.00128	CbGpPWpGaD
Memantine—Diarrhoea—Betaxolol—glaucoma	0.000102	0.000181	CcSEcCtD
Memantine—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	0.000102	0.00127	CbGpPWpGaD
Memantine—Nausea—Clonidine—glaucoma	0.000102	0.00018	CcSEcCtD
Memantine—Feeling abnormal—Timolol—glaucoma	0.000101	0.000178	CcSEcCtD
Memantine—Gastrointestinal pain—Timolol—glaucoma	0.0001	0.000177	CcSEcCtD
Memantine—Dizziness—Betaxolol—glaucoma	9.91e-05	0.000175	CcSEcCtD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.76e-05	0.00121	CbGpPWpGaD
Memantine—Urticaria—Timolol—glaucoma	9.72e-05	0.000172	CcSEcCtD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.69e-05	0.0012	CbGpPWpGaD
Memantine—Abdominal pain—Timolol—glaucoma	9.67e-05	0.000171	CcSEcCtD
Memantine—Body temperature increased—Timolol—glaucoma	9.67e-05	0.000171	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—PTGFR—glaucoma	9.63e-05	0.0012	CbGpPWpGaD
Memantine—Vomiting—Betaxolol—glaucoma	9.52e-05	0.000168	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—SMO—glaucoma	9.46e-05	0.00117	CbGpPWpGaD
Memantine—Rash—Betaxolol—glaucoma	9.44e-05	0.000167	CcSEcCtD
Memantine—Dermatitis—Betaxolol—glaucoma	9.44e-05	0.000166	CcSEcCtD
Memantine—Headache—Betaxolol—glaucoma	9.38e-05	0.000166	CcSEcCtD
Memantine—CYP2C19—Metabolism—CA5A—glaucoma	9.12e-05	0.00113	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NARFL—glaucoma	9.12e-05	0.00113	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LRP12—glaucoma	9.12e-05	0.00113	CbGpPWpGaD
Memantine—Hypersensitivity—Timolol—glaucoma	9.02e-05	0.000159	CcSEcCtD
Memantine—DRD2—G alpha (i) signalling events—C3—glaucoma	9e-05	0.00112	CbGpPWpGaD
Memantine—Nausea—Betaxolol—glaucoma	8.9e-05	0.000157	CcSEcCtD
Memantine—Asthenia—Timolol—glaucoma	8.78e-05	0.000155	CcSEcCtD
Memantine—Pruritus—Timolol—glaucoma	8.66e-05	0.000153	CcSEcCtD
Memantine—GRIN1—Axon guidance—MMP9—glaucoma	8.49e-05	0.00105	CbGpPWpGaD
Memantine—Diarrhoea—Timolol—glaucoma	8.37e-05	0.000148	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—GSTM1—glaucoma	8.29e-05	0.00103	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MMP9—glaucoma	8.28e-05	0.00103	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	8.19e-05	0.00102	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	8.18e-05	0.00102	CbGpPWpGaD
Memantine—Dizziness—Timolol—glaucoma	8.09e-05	0.000143	CcSEcCtD
Memantine—GRIN1—Developmental Biology—MMP2—glaucoma	8.06e-05	0.001	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CA1—glaucoma	7.96e-05	0.000988	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP2—glaucoma	7.86e-05	0.000976	CbGpPWpGaD
Memantine—Vomiting—Timolol—glaucoma	7.78e-05	0.000137	CcSEcCtD
Memantine—Rash—Timolol—glaucoma	7.72e-05	0.000136	CcSEcCtD
Memantine—SLC22A2—Metabolism—CTSA—glaucoma	7.71e-05	0.000957	CbGpPWpGaD
Memantine—Dermatitis—Timolol—glaucoma	7.71e-05	0.000136	CcSEcCtD
Memantine—Headache—Timolol—glaucoma	7.67e-05	0.000135	CcSEcCtD
Memantine—GRIN1—Axon guidance—VEGFA—glaucoma	7.62e-05	0.000946	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—glaucoma	7.43e-05	0.000923	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CA1—glaucoma	7.31e-05	0.000907	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CA2—glaucoma	7.28e-05	0.000904	CbGpPWpGaD
Memantine—Nausea—Timolol—glaucoma	7.27e-05	0.000128	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	7.16e-05	0.000888	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CTSA—glaucoma	7.08e-05	0.000879	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CA2—glaucoma	6.68e-05	0.00083	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—OPN4—glaucoma	6.32e-05	0.000784	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—EDN1—glaucoma	6.24e-05	0.000774	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP9—glaucoma	6.06e-05	0.000752	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP9—glaucoma	5.91e-05	0.000733	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CA1—glaucoma	5.9e-05	0.000732	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HEYL—glaucoma	5.87e-05	0.000729	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CTSA—glaucoma	5.71e-05	0.000709	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTGFR—glaucoma	5.69e-05	0.000706	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—C3—glaucoma	5.45e-05	0.000677	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—glaucoma	5.44e-05	0.000675	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CA2—glaucoma	5.39e-05	0.000669	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—glaucoma	5.3e-05	0.000658	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TXN—glaucoma	5.13e-05	0.000637	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SMO—glaucoma	4.86e-05	0.000603	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TXN—glaucoma	4.71e-05	0.000585	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—glaucoma	4.66e-05	0.000579	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—glaucoma	4.55e-05	0.000564	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CA1—glaucoma	4.46e-05	0.000553	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RPTOR—glaucoma	4.45e-05	0.000553	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CTSA—glaucoma	4.31e-05	0.000536	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NCK2—glaucoma	4.31e-05	0.000535	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CA2—glaucoma	4.07e-05	0.000506	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.98e-05	0.000494	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.98e-05	0.000494	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTT1—glaucoma	3.98e-05	0.000494	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—glaucoma	3.87e-05	0.000481	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TXN—glaucoma	3.8e-05	0.000472	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HDAC9—glaucoma	3.67e-05	0.000455	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTT1—glaucoma	3.65e-05	0.000453	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—EDN1—glaucoma	3.53e-05	0.000438	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EDN1—glaucoma	3.2e-05	0.000397	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP1B1—glaucoma	3.17e-05	0.000393	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCA1—glaucoma	3.17e-05	0.000393	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—C3—glaucoma	3.08e-05	0.000382	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTT1—glaucoma	2.95e-05	0.000366	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCA1—glaucoma	2.91e-05	0.000361	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1B1—glaucoma	2.91e-05	0.000361	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TXN—glaucoma	2.87e-05	0.000356	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SMO—glaucoma	2.87e-05	0.000356	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—C3—glaucoma	2.8e-05	0.000347	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NTRK2—glaucoma	2.62e-05	0.000326	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.62e-05	0.000325	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.6e-05	0.000322	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTM1—glaucoma	2.53e-05	0.000314	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1B1—glaucoma	2.35e-05	0.000291	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCA1—glaucoma	2.35e-05	0.000291	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTM1—glaucoma	2.33e-05	0.000289	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NGFR—glaucoma	2.25e-05	0.000279	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MTHFR—glaucoma	2.24e-05	0.000278	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTT1—glaucoma	2.23e-05	0.000276	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NTRK1—glaucoma	2.14e-05	0.000266	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOE—glaucoma	2.08e-05	0.000259	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CAV1—glaucoma	2.07e-05	0.000256	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MTHFR—glaucoma	2.06e-05	0.000255	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN2B—glaucoma	1.97e-05	0.000245	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOE—glaucoma	1.91e-05	0.000238	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CAV1—glaucoma	1.9e-05	0.000235	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EDN1—glaucoma	1.89e-05	0.000235	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTM1—glaucoma	1.88e-05	0.000233	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.79e-05	0.000223	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1B1—glaucoma	1.77e-05	0.00022	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCA1—glaucoma	1.77e-05	0.00022	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NGF—glaucoma	1.74e-05	0.000216	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MTHFR—glaucoma	1.66e-05	0.000206	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—C3—glaucoma	1.65e-05	0.000205	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NOS3—glaucoma	1.56e-05	0.000194	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOE—glaucoma	1.54e-05	0.000192	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOE—glaucoma	1.54e-05	0.000191	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CAV1—glaucoma	1.53e-05	0.00019	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CAV1—glaucoma	1.52e-05	0.000189	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FN1—glaucoma	1.45e-05	0.00018	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NOS3—glaucoma	1.43e-05	0.000178	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BAD—glaucoma	1.43e-05	0.000178	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—glaucoma	1.43e-05	0.000177	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTM1—glaucoma	1.42e-05	0.000176	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—glaucoma	1.31e-05	0.000163	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTHFR—glaucoma	1.25e-05	0.000156	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOE—glaucoma	1.17e-05	0.000145	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NOS3—glaucoma	1.16e-05	0.000144	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CAV1—glaucoma	1.16e-05	0.000143	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOS3—glaucoma	1.15e-05	0.000143	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—glaucoma	1.06e-05	0.000131	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1B—glaucoma	9.98e-06	0.000124	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—glaucoma	9.25e-06	0.000115	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NOS3—glaucoma	8.74e-06	0.000109	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—glaucoma	8.3e-06	0.000103	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—glaucoma	7.99e-06	9.92e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—glaucoma	6.27e-06	7.79e-05	CbGpPWpGaD
